<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<title>Ministry of Health &amp; Welfare : ABOUT MOHW &gt; Press Release View Content</title>
<link href="../../css/eng/mwf_eng.css" rel="stylesheet" type="text/css"/>
<script src="../../js/jquery-1.11.0.min.js" type="text/javascript"></script>
<script src="../../js/common.js" type="text/javascript"></script>
<script src="../../js/mw_eng.js" type="text/javascript"></script>
<script type="text/javascript">

//<![CDATA[



	// ¸®½ºÆ®·Î ÀÌµ¿

	function jsList()

	{

		var form = document.fmList;

		form.action = "ssg0111ls.jsp";

		form.submit();

	}



	//³»¿ë º¸±â

	function goView(seq)

	{

		var form = document.fmView;

		form.CONT_SEQ.value = seq;

		form.action = "ssg0111vw.jsp";

		form.submit();

	}



	//ÇÏ´Ü ¸®½ºÆ® ÆäÀÌÁö ÀÌµ¿

	function goPage( page)

	{

		var form = document.fmList;

		form.page.value = page;

		form.submit();

	}



	//ÆÄÀÏ ´Ù¿î·Îµå.

	function fileDownLoad(fileSeq)

	{

		if( confirm( "Do you wish to download now?") == true ) {

			var form = document.fmView;

			form.FILE_SEQ.value = fileSeq;

			form.action = "/front_new/modules/download.jsp";

			form.submit();

		}

	}

//]]>

</script>
</head>
<body>
<!-- ¹Ù·Î°¡±â ¸µÅ© -->
<p id="skip-navi">
<a href="#contents">go to the contents</a>
<a href="#snb">go to the menu</a>
</p>
<!-- //¹Ù·Î°¡±â ¸µÅ© -->
<!-- header -->
<div id="wrap">
<!-- head -->
<div class="sbHead" id="head">
<!-- header -->
<div id="header">
<!-- ·Î°í -->
<h1 class="logo"><a href="../261f58801c1da21d0b6f7021b30b648b"><img alt="ministry of health and welfare" src="../../images/eng/common/logo.gif"/></a></h1>
<div class="kor_sym">
<a href="../../../moi.go.kr/eng/sub/a03/nationalSymbol/d5a2e22490af7d4414516807b47a6064" target="_blank" title="new browser"><img alt="National Symbols of the Republic of Korea" src="../../images/eng/common/kor_sym_eng.gif"/></a>
</div>
<!-- function -->
<div class="function">
<!-- [Funciton] - ÆùÆ®»çÀÌÁî -->
<div class="unit">
<div class="ft_size">
<button class="plus" onclick="fontSizeWrap.btnPlus();" type="button"><span class="hide">expand</span></button>
<button class="minus" onclick="fontSizeWrap.btnMinus();" type="button"><span class="hide">reduce</span></button>
<span class="Font_Size"><span class="hide">Font Size</span></span>
</div>
<script type="text/javascript">var fontSizeWrap = new fontSize();</script>
<!-- //[Funciton] - ÆùÆ®»çÀÌÁî -->
<!-- ¾ð¾îº° ¸µÅ© -->
<ul class="global_language">
<li class="mobile"><a href="../../m_eng/50b06ecdc2a14f90913d780c3460fca4" target="_blank" title="new browser"><span class="hide">Mobile</span></a></li>
<li class="Korean"><a href="../../front_new/647a6a76a15a5a8bfc6d5f73d0d9d4d1" target="_blank" title="new browser"><span class="hide">Korean</span></a></li>
<li class="sitemap"><a href="../cs/38f03257ef34df8e601ed2e794b4f84f"><span class="hide">sitemap</span></a></li>
<li class="a-z"><a href="../cs/1001c96bb6754f09ed925f7b6d593bf7"><span class="hide">A-Z Index</span></a></li>
</ul>
<!-- //¾ð¾îº° ¸µÅ© -->
<!-- ¸Þ´º¼³Á¤ -->
<div class="mnsetup">
<div class="btnsetup"><a class="btnms" href="#msetup_layer" id="svcmore_h"><span class="hide">my menu</span></a></div>
<div class="msetup_layer" id="msetup_layer">
<h2>
<img alt="Menu setup" src="../../images/eng/main/musetup.gif"/>
</h2>
<div class="mnsetup_cont">
<ul class="list" id="fmenu"><li>My menu list</li></ul>
</div>
<div class="cg_contwrap">
<div class="cg_cont">
<!-- ÀüÃ¼¸ñ·Ï -->
<ul class="ms_category">
<li>
<input class="input-check" id="mw_100103" name="setmenu" type="checkbox" value="/eng/sg/ssg0103mn.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100103|100103|Organization"/>
<label for="mw_100103">Organization</label>
</li>
<li>
<input class="input-check" id="mw_100113" name="setmenu" type="checkbox" value="/eng/sg/ssg0101mn.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100113|100113|Contact Us"/>
<label for="mw_100113">Contact Us</label>
</li>
<li>
<input class="input-check" id="mw_100105" name="setmenu" type="checkbox" value="/eng/sg/ssg0105mn.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100105|100105|Minister's Profile"/>
<label for="mw_100105">Minister's Profile</label>
</li>
<li>
<input class="input-check" id="mw_100111" name="setmenu" type="checkbox" value="/eng/sg/ssg0111ls.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100111|100111|Press Release"/>
<label for="mw_100111">Press Release</label>
</li>
<li>
<input class="input-check" id="mw_10031801" name="setmenu" type="checkbox" value="/eng/jc/sjc0101mn.jsp?PAR_MENU_ID=1003&amp;MENU_ID=10031801|10031801|Policies"/>
<label for="mw_10031801">Policies</label>
</li>
<li>
<input class="input-check" id="mw_100408" name="setmenu" type="checkbox" value="/eng/cs/scs0301mn.jsp?PAR_MENU_ID=1004&amp;MENU_ID=100408|100408|RSS"/>
<label for="mw_100408">RSS</label>
</li>
<li>
<input class="input-check" id="mw_100410" name="setmenu" type="checkbox" value="/eng/cs/scs0301mn.jsp?PAR_MENU_ID=1004&amp;MENU_ID=100410|100410|Privacy Guideline"/>
<label for="mw_100410">Privacy Guideline</label>
</li>
<li>
<input class="input-check" id="mw_100404" name="setmenu" type="checkbox" value="/eng/cs/scs0301mn.jsp?PAR_MENU_ID=1004&amp;MENU_ID=100404|100404|Users Guide"/>
<label for="mw_100404">Users Guide</label>
</li>
</ul>
<!-- //ÀüÃ¼¸ñ·Ï -->
</div>
<!-- ¹öÆ° Á¤·Ä -->
<div class="btn_msetup">
<p class="left"><input alt="default" class="input-image" id="mymenu_default" src="/images/eng/btn/btn_base.gif" type="image"/></p>
<span class="cg_msg">User can personalize the website</span>
<p class="center">
<input alt="confirm" class="input-image" id="mymenu_set" src="/images/eng/btn/btn_confirm.gif" type="image"/>
<!--a href="#" id="mymenu_set" ><img src="/images/front/btn/btn_confirm.gif" alt="È®ÀÎ" /></a-->
<input alt="cancel" class="input-image" id="mymenu_cancel" src="/images/eng/btn/btn_cancel.gif" type="image"/>
</p>
<p class="right"><a href="../cs/38f03257ef34df8e601ed2e794b4f84f">sitemap</a></p>
</div>
<!-- //¹öÆ° Á¤·Ä -->
</div>
<p class="btn-more"><button class="msbtn_close" id="msbtn_close" type="button"><span class="hide">close</span></button></p>
</div>
</div>
<!-- //¸Þ´º¼³Á¤ -->
<!-- °Ë»ö -->
<!-- 

					<div class="search">

						<form method="post" name="fmSearch" action="/eng/cs/scs0401ls.jsp" onsubmit="return searchCommon(this)" >

							<input type="hidden" name="PAR_MENU_ID" value="1004" />

							<input type="hidden" name="MENU_ID" value="100406" />

							<input type="hidden" name="SEARCHKEY" value="TITLE" />				

							<fieldset>

								<legend>search</legend>

								<label for="SEARCHVALUE" class="hide">search value</label>

								<input type="text" id="SEARCHVALUE" name="SEARCHVALUE" class="input-text" />

								<input type="image" class="input-image" src="/images/eng/common/tl_btnsearch.gif" alt="search" />

							</fieldset>

						</form>

					</div>

					 -->
<!-- //°Ë»ö -->
</div><!-- //unit -->
</div>
<!-- //function -->
</div>
<!-- //header -->
</div>
<!-- //head -->
<hr/>
<!-- spot main -->
<div id="spot-sub">
<img alt="A life-long friend who stands by the public" src="../../images/front_eng/sg/img_head_sg.jpg"/>
</div>
<!-- //spot main -->
<hr/>
<!-- container -->
<div class="clear" id="container">
<div id="subwrap">
<!-- snb -->
<div id="snb">
<h2><a href="616feca8de871f8a1f1e040342b5d550"><img alt="About MW" src="../../images/front_eng/title/h2_am.gif"/></a></h2>
<ul id="snbMenu1">
<li><a href="616feca8de871f8a1f1e040342b5d550"><img alt="Vision &amp; Mission" src="../../images/front_eng/title/left_am01.gif"/></a>
</li>
<li><a href="93dae7d73a99735630654fc2fb46a9eb"><img alt="Organization" src="../../images/front_eng/title/left_am02.gif"/></a>
</li>
<li><a href="482124899dc6a43227599ea28a921fea"><img alt="Contact Us" src="../../images/front_eng/title/left_am03.gif"/></a>
</li>
<li><a href="2d75b746f82cbae41316bd3da4ceb30d"><img alt="Minister¡¯s Profile" src="../../images/front_eng/title/left_am04.gif"/></a>
</li>
<li><a href="a2fde158a68020769e116fe2815d95aa"><img alt="Vice Minister¡¯s Profile" src="../../images/front_eng/title/left_am05.gif"/></a>
</li>
<li><a href="8c6914a853d28a0cf2ce417c6d5fe3ce"><img alt="Past Ministers &amp; Vice Ministers" src="../../images/front_eng/title/left_am06.gif"/></a>
</li>
<li><a href="a79fdae6ffae612a0b5f784645afb1db"><img alt="Location" src="../../images/front_eng/title/left_am07.gif"/></a>
</li>
<li class="on"><a href="76b19fd6a92fcb216e55a4e9dea9a4c8"><img alt="Press Release" src="../../images/front_eng/title/left_am08_over.gif"/></a>
</li>
<li><a href="ea8a1ea6f8dcdcb2b03b8ebc89df5ef6"><img alt="129 Call Center" src="../../images/front_eng/title/left_am09.gif"/></a>
</li>
<li><a href="../../../www.epeople.go.kr/jsp/user/on/eng/ebb342dee28c17242d927d0b1019800f" target="_blank"><img alt="Online Petition" src="../../images/front_eng/title/left_am10.gif"/></a>
</li>
</ul>
<h2><a href="../jc/f397eab66fb162470b191bcc18dfac4f"><img alt="Policies" src="../../images/front_eng/title/h2_pl.gif"/></a></h2>
<ul id="snbMenu2">
<li class="submenu"><img alt="Enhancement of Customized Welfare Services by Life-Cycle Phase" src="../../images/front_new/title/left_pl100321.gif"/>
<ul>
<li><a href="../jc/f397eab66fb162470b191bcc18dfac4f"><img alt="Reinforcement of support for income growth and work opportunities of low-income people" src="../../images/front_new/title/left_pl10032101.gif"/></a></li>
<li><a href="../jc/6d963af417c35f2c3575a2f47d93315d"><img alt="Welfare services reaching out to people and improvement of public perception" src="../../images/front_new/title/left_pl10032102.gif"/></a></li>
<li><a href="../jc/7c117d987132de318dd869c7e15cd6d1"><img alt="Promotion of rights and interests of children, the disabled, the elderly, etc." src="../../images/front_new/title/left_pl10032103.gif"/></a></li>
<li><a href="../jc/3cd7dc5b01d534d90eba055e35cdf386"><img alt="Reduction of burden of medical expenses, and the reorganization of the system for determining health insurance premiums" src="../../images/front_new/title/left_pl10032104.gif"/></a></li>
</ul>
</li>
<li class="submenu"><img alt="Establishment of Health Insurance System centered on People" src="../../images/front_new/title/left_pl100322.gif"/>
<ul>
<li><a href="../jc/6698fa46cb8d35f0f8aeb6f289ab2ce9"><img alt="Reinforcement of patient-oriented medical services" src="../../images/front_new/title/left_pl10032201.gif"/></a></li>
<li><a href="../jc/6194a5e0555dab84754814c541f09b27"><img alt="Strengthening of essential and public health care services and systematic response to infectious diseases" src="../../images/front_new/title/left_pl10032202.gif"/></a></li>
<li><a href="../jc/7603054a50c83c708da6d6702afe3d14"><img alt="Reinforcement of Preventive Health Care" src="../../images/front_new/title/left_pl10032203.gif"/></a></li>
<li><a href="../jc/5975190b9def38149afd3ad48132162f"><img alt="Enhancement of healthcare industry performance and job creation" src="../../images/front_new/title/left_pl10032204.gif"/></a></li>
</ul>
</li>
<li class="submenu"><img alt="Strengthening Responses to Demographic Crisis" src="../../images/front_new/title/left_pl100323.gif"/>
<ul>
<li><a href="../jc/8334fe91b7312eb840b99581e90bc297"><img alt="Establishment of a response system for coping with low birthrate" src="../../images/front_new/title/left_pl10032301.gif"/></a></li>
<li><a href="../jc/687f9bcd11741aea5264c8392dc17ffc"><img alt="Improvement of a system for supporting childbirth and parenting" src="../../images/front_new/title/left_pl10032302.gif"/></a></li>
<li><a href="../jc/d59e41ec8156d3ed1193b5f64629cf85"><img alt="Enhancement of preparation for aging society" src="../../images/front_new/title/left_pl10032303.gif"/></a></li>
</ul>
</li>
</ul>
<h2><a href="../cs/b64cc4894874ba0eb4af154d245908a9"><img alt="Help" src="../../images/front_eng/title/h2_hp.gif"/></a></h2>
<ul id="snbMenu3">
<li><a href="../cs/b64cc4894874ba0eb4af154d245908a9"><img alt="Users Guide" src="../../images/front_eng/title/left_hp01.gif"/></a>
</li>
<li><a href="../cs/81e6dbd0ed113665170a29b899ab0c21"><img alt="Privacy Guideline" src="../../images/front_eng/title/left_hp04.gif"/></a>
</li>
<li><a href="../cs/bab2f9d80d5980695b6081cb22ceb64b"><img alt="RSS" src="../../images/front_eng/title/left_hp03.gif"/></a>
</li>
<li><a href="../cs/38f03257ef34df8e601ed2e794b4f84f"><img alt="Sitemap" src="../../images/front_eng/title/left_hp05.gif"/></a>
</li>
<li><a href="../cs/1001c96bb6754f09ed925f7b6d593bf7"><img alt="A-Z Index" src="../../images/front_eng/title/left_hp06.gif"/></a>
</li>
</ul>
</div>
<script src="../../js/jquery-1.11.0.min.js" type="text/javascript"></script>
<script type="text/javascript">
			$('.submenu').last().find('ul').attr('class', 'noline');
			imgMenuOver("snb");
			
			$(function(){
				$(".on").parents('ul').slideDown();
			});	
			
			$(".submenu").click(function(){
				$(".submenu").not($(this)).children('ul').slideUp();
				$(this).children('ul').slideToggle();
			});
		</script>
<!-- //snb -->
<!-- contents -->
<div id="contents">
<!-- mnvisual - ÄÁÅÙÃ÷ Å¸ÀÌÆ² -->
<div class="mnvisual">
<!-- h2 - Å¸ÀÌÆ² -->
<!-- //h2 - Å¸ÀÌÆ² -->
<!-- location - ÁÖ¼Ò -->
<div id="location"> <a class="home" href="../261f58801c1da21d0b6f7021b30b648b">HOME</a> &gt; <a href="616feca8de871f8a1f1e040342b5d550">ABOUT MOHW</a> &gt; <span class="here">Press Release</span></div>
<!-- //location - ÁÖ¼Ò -->
</div>
<!-- //mnvisual - ÄÁÅÙÃ÷ Å¸ÀÌÆ² -->
<!-- content-area -->
<div class="content-area">
<!-- DB ¿¡¼­ contents µ¥ÀÌÅÍ¸¦ °¡Á®¿Í¼­ »Ñ·ÁÁØ´Ù. -->
<!-- board -->
<form action="ssg0111vw.jsp" method="post" name="fmView">
<input name="PAR_MENU_ID" type="hidden" value="1001"/>
<input name="MENU_ID" type="hidden" value="100111"/>
<input name="page" type="hidden" value="19"/>
<input name="CONT_SEQ" type="hidden" value="318824"/>
<input name="MENU_ID" type="hidden" value="100111"/>
<input name="FILE_SEQ" type="hidden" value=""/>
<input name="SEARCHKEY" type="hidden" value=""/>
<input name="SEARCHVALUE" type="hidden" value=""/>
<!-- table:view -->
<table class="view" summary="ABOUT MOHW &gt; Press Release detail.">
<caption>ABOUT MOHW &gt; Press Release</caption>
<colgroup>
<col width="12%"/><col width="38%"/><col width="12%"/><col width="38%"/>
</colgroup>
<tbody>
<tr>
<th scope="row">Subject</th>
<td colspan="3">Government Unveils a Blueprint for the Healthcare Industry</td>
</tr>
<tr>
<th scope="row">Date</th>
<td>2015-04-23</td>
<th scope="row">Hit</th>
<td>2375</td>
</tr>
<tr>
<th scope="row">Contents</th>
<td class="view" colspan="3"><p align="center" class="a" style="text-align: center; line-height: 107%; margin: 0cm 0cm 8pt; word-break: keep-all">
<b style="mso-bidi-font-weight: normal"><u><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; background: white; font-size: 14pt; mso-fareast-font-family: hyÇìµå¶óÀÎm"><font color="#000000"><font face="Times New Roman">Government Unveils a Blueprint for the Healthcare Industry<o:p></o:p></font></font></span></u></b></p>
<p align="center" class="MsoNormal" style="text-align: center; margin: 0cm 0cm 8pt; background: white; vertical-align: baseline; word-break: keep-all">
<b><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; background: white; letter-spacing: -0.5pt; color: black; font-size: 12pt; mso-fareast-font-family: ÇÑ¾çÁß°íµñ; mso-font-kerning: 0pt"><font face="Times New Roman">- The Ministry of Health and Welfare presents a policy vision for the healthcare industry at the ‘2015 Bio &amp; Medical Korea’ held during Aug 8-10 at COEX convention center in Seoul -<o:p></o:p></font></span></b></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font face="Times New Roman"> </font></o:p></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font face="Times New Roman"><font color="#000000">The Ministry of Health and Welfare (Minister: Moon Hyung-pyo) announced the ‘Healthcare Industry Promotion Plan’ at the conference held at COEX center on April 8 as a part of events held during ‘Bio-Medical Korea’ week. <o:p></o:p></font></font></span></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l2 level1 lfo1">
<font color="#000000"><font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">          </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt">The health industry, one of the government’s key national policy agenda, has been producing tangible results recently, such as successful medical exports and medical tourist attraction, and it has been gaining importance as a future growth engine.<span style="mso-spacerun: yes">  </span><o:p></o:p></span></font></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt 20pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 2.0gd">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font color="#000000"><font face="Times New Roman">Against this backdrop, the government held a conference to present policy direction of the healthcare industry so as to ensure every participant in the industry understands the general structure, shares the goal, and promotes collaboration. <o:p></o:p></font></font></span></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l2 level1 lfo1">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">          </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; background: white; color: black; font-size: 12pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-font-kerning: 0pt">Although there were basic plan for each sub-sector such as medicine and medical devices, the plan is the first of its kind to present the policy direction of the whole healthcare industry. </span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font face="Times New Roman"><font color="#000000">Global healthcare industry amounts to 8 thousand trillion won in value and with convergence technologies such as IT, BT, and NT, the healthcare industry is expected to create jobs and high added values. <o:p></o:p></font></font></span></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; mso-para-margin-left: 0gd; mso-list: l2 level1 lfo1">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">          </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt">The Ministry of Health and Welfare believes that Korea’s competitiveness in the healthcare industry is strong considering that Korea has the world’s top class medical personnel, technologies and infrastructure.<span style="mso-spacerun: yes">  </span><o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; mso-para-margin-left: 0gd; mso-list: l2 level1 lfo1">
<font color="#000000"><font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">          </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt">Given that the developed countries, such as Japan, the UK and Singapore are striving hard to export their medical business models, it is high time for Korea to make an aggressive investment in order to gain a competitive edge in the global healthcare market and to created jobs and added values and to promote the health of humankind. <o:p></o:p></span></font></font></p>
<p>
	 </p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-bottom: medium none; border-left: medium none; margin: auto auto auto 5.1pt; width: 451pt; border-collapse: collapse; border-top: medium none; border-right: medium none; mso-border-alt: solid black .25pt; mso-table-overlap: never; mso-yfti-tbllook: 1184" width="601">
<tbody>
<tr style="height: 129.35pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">
<td style="border-bottom: black 1pt dotted; border-left: black 1pt dotted; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 451pt; padding-right: 5.1pt; height: 129.35pt; border-top: black 1pt dotted; border-right: black 1pt dotted; padding-top: 1.4pt; mso-border-alt: dotted black .25pt" width="601">
<p class="MsoNormal" style="margin: 0cm 0cm 8pt">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; letter-spacing: -0.3pt; color: black; font-size: 12pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-font-kerning: 0pt">(</span><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font color="#000000">Japan) As a part of Abenomics, the Japanese government has been driving the globalization of its healthcare industry. To this end, it has been making necessary investments and improving the regulatory framework.<span style="mso-spacerun: yes">  </span><o:p></o:p></font></span></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font color="#000000"><font face="Times New Roman">(UK) The British government invested 3.4 trillion won (18 percent of the whole R&amp;D expenditure) in healthcare R&amp;D during 2011 and 2012, and is trying to make inroads into the Middle East market via a dedicated public agency (Healthcare UK). <o:p></o:p></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt">
<font color="#000000"><font face="Times New Roman"><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt">(Singapore) Singapore chose bio medicine as its future growth engine, and has been making intensive investments in life science R&amp;D center (Biopolis) and biomedicine clusters. </span><span lang="EN-US" style="line-height: 107%; font-family: '¹ÙÅÁ', 'serif'; color: black; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p></o:p></span></font></font></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="margin: 8pt 0cm">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font color="#000000"><font face="Times New Roman">‘Healthcare Industry Promotion Plan’ is composed of five strategies. They are: 1) promoting areas where Korea has comparative edge, 2) accelerating R&amp;D commercialization 3) creating new markets through convergence between industries and globalization, 4) building infrastructure for all stages involving healthcare, and 5) developing talents. <o:p></o:p></font></font></span></p>
<p align="center" class="MsoNormal" style="text-align: center; margin: 0cm 0cm 8pt">
<b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; font-size: 12pt"><font color="#000000"><font face="Times New Roman">&lt; Five Strategies for the Healthcare Industry Promotion&gt;<o:p></o:p></font></font></span></b></p>
<p>
	 </p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-bottom: medium none; border-left: medium none; border-collapse: collapse; border-top: medium none; border-right: medium none; mso-border-alt: solid black .25pt; mso-table-overlap: never; mso-yfti-tbllook: 1184">
<tbody>
<tr style="height: 1.75pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">
<td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 451.65pt; padding-right: 5.1pt; height: 1.75pt; border-top: black 1pt solid; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt" width="602">
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-bottom: medium none; border-left: medium none; width: 440.5pt; border-collapse: collapse; border-top: medium none; border-right: medium none; mso-border-alt: solid black .25pt; mso-table-overlap: never; mso-yfti-tbllook: 1184" width="587">
<tbody>
<tr style="height: 23.3pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes">
<td colspan="2" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 264.55pt; padding-right: 5.1pt; height: 23.3pt; border-top: black 1pt solid; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt" width="353">
<p align="center" class="MsoNormal" style="text-align: center; line-height: 130%; margin: 0cm 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 130%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">Competitiveness Reinforcement</span><span lang="EN-US" style="line-height: 130%; font-family: '¹ÙÅÁ', 'serif'; color: black; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p></o:p></span></p>
</td>
<td style="border-bottom: #000000; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 12.9pt; padding-right: 5.1pt; height: 23.3pt; border-top: #000000; border-right: #000000; padding-top: 1.4pt; mso-border-left-alt: solid black .25pt" width="17">
								 </td>
<td style="border-bottom: #000000; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 12.9pt; padding-right: 5.1pt; height: 23.3pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-right-alt: solid black .25pt" width="17">
								 </td>
<td style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 150.15pt; padding-right: 5.1pt; height: 23.3pt; border-top: black 1pt solid; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-left-alt: solid black .25pt" width="200">
<p class="MsoNormal" style="margin: 0cm 0cm 8pt; word-break: keep-all; mso-pagination: widow-orphan">
<span lang="EN-US" style="line-height: 107%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="">Market Creation<o:p></o:p></font></span></p>
</td>
</tr>
<tr style="height: 30.4pt; mso-yfti-irow: 1">
<td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; padding-left: 5.1pt; width: 128.75pt; padding-right: 5.1pt; background: #ffff93; height: 30.4pt; border-top: #000000; border-right: black 2.25pt double; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-right-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" width="172">
<p align="left" class="MsoNormal" style="text-align: left; margin: 0cm 0cm 8pt; word-break: keep-all; mso-pagination: widow-orphan">
<span lang="EN-US" style="line-height: 107%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="">1. Developing Comparative Advantage Areas <o:p></o:p></font></span></p>
</td>
<td style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 1.4pt; padding-left: 5.1pt; width: 135.8pt; padding-right: 5.1pt; background: #ffff93; height: 30.4pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-left-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" width="181">
<p align="left" class="MsoNormal" style="text-align: left; margin: 0cm 0cm 8pt; word-break: keep-all; mso-pagination: widow-orphan">
<span lang="EN-US" style="line-height: 107%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="">2. Accelerating the Commercialization of <span style="mso-spacerun: yes"> </span>R&amp;D<o:p></o:p></font></span></p>
</td>
<td style="border-bottom: #000000; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 12.9pt; padding-right: 5.1pt; height: 30.4pt; border-top: #000000; border-right: #000000; padding-top: 1.4pt; mso-border-left-alt: solid black .25pt" width="17">
								 </td>
<td style="border-bottom: #000000; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 12.9pt; padding-right: 5.1pt; height: 30.4pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-right-alt: solid black .25pt" width="17">
								 </td>
<td style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 1.4pt; padding-left: 5.1pt; width: 150.15pt; padding-right: 5.1pt; background: #ffff93; height: 30.4pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-left-alt: solid black .25pt; mso-border-top-alt: solid black .25pt" width="200">
<p align="left" class="MsoNormal" style="text-align: left; margin: 0cm 0cm 8pt; word-break: keep-all; mso-pagination: widow-orphan">
<span lang="EN-US" style="line-height: 107%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="">3. Creating Markets through Convergence and Globalization <o:p></o:p></font></span></p>
</td>
</tr>
<tr style="height: 120.65pt; mso-yfti-irow: 2">
<td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 128.75pt; padding-right: 5.1pt; height: 120.65pt; border-top: #000000; border-right: black 2.25pt double; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-right-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" valign="top" width="172">
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(1)<span style="letter-spacing: -0.2pt"> Overseas Market Entry </span></span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt"><font face="Times New Roman">(2) Medical Tourists <o:p></o:p></font></span></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(3) Blockbuster Drugs </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(4) Global Generics </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
<td style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 135.8pt; padding-right: 5.1pt; height: 120.65pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-left-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" valign="top" width="181">
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(1) Genome &amp; Customized Treatment </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; letter-spacing: -0.1pt; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(2) Stem Cell &amp; Regenerative Medicine </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; text-indent: -20.2pt; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; letter-spacing: 0.1pt; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(3) (3) Antibiotics </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; text-indent: -20.2pt; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; letter-spacing: -0.1pt; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(4) (4) High-tech Medical Devices </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; text-indent: -20pt; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(5) (5) Promoting Healthcare Technology License Office (TLO)</span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
<td style="border-bottom: #000000; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 12.9pt; padding-right: 5.1pt; height: 120.65pt; border-top: #000000; border-right: #000000; padding-top: 1.4pt; mso-border-left-alt: solid black .25pt" valign="top" width="17">
								 </td>
<td style="border-bottom: #000000; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 12.9pt; padding-right: 5.1pt; height: 120.65pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-right-alt: solid black .25pt" valign="top" width="17">
								 </td>
<td style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 150.15pt; padding-right: 5.1pt; height: 120.65pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-left-alt: solid black .25pt; mso-border-top-alt: solid black .25pt" valign="top" width="200">
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; letter-spacing: -0.2pt; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(1) Healthcare Product Exports </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(2) Beauty Industry </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(3) Botanical Drug </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt">(4) Healthy Aging Industry </span><span lang="EN-US" style="line-height: 130%; font-family: 'times new roman', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
</tr>
<tr style="height: 14.8pt; mso-yfti-irow: 3">
<td colspan="5" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 440.5pt; padding-right: 5.1pt; height: 14.8pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-top-alt: solid black .25pt" width="587">
<p align="center" class="MsoNormal" style="text-align: center; line-height: 130%; margin: 0cm 0cm 0pt; background: white; vertical-align: baseline">
<font face=""><span lang="EN-US" style="line-height: 130%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">Building Infrastructure</span><span lang="EN-US" style="line-height: 130%; font-family: '¹ÙÅÁ', 'serif'; color: black; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
</tr>
<tr style="height: 23.3pt; mso-yfti-irow: 4">
<td colspan="3" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; padding-left: 5.1pt; width: 277.45pt; padding-right: 5.1pt; background: #ffff93; height: 23.3pt; border-top: #000000; border-right: black 2.25pt double; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-right-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" width="370">
<p class="MsoNormal" style="margin: 0cm 0cm 8pt; word-break: keep-all; mso-pagination: widow-orphan">
<span lang="EN-US" style="line-height: 107%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="">4. Building Infrastructure for All Stages Involving Healthcare <o:p></o:p></font></span></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 0.75pt; padding-left: 0.75pt; width: 163.05pt; padding-right: 0.75pt; background: #ffff93; height: 23.3pt; border-top: #000000; border-right: black 1pt solid; padding-top: 0.75pt; mso-border-alt: solid black .25pt; mso-border-left-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" width="217">
<p class="MsoNormal" style="text-indent: 6pt; margin: 0cm 0cm 8pt; word-break: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5">
<font face=""><span lang="EN-US" style="line-height: 107%; font-family: 'hyÇìµå¶óÀÎm', 'serif'; color: black; font-size: 12pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">5. Developing Talents </span><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 10.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
</tr>
<tr style="height: 26.15pt; mso-yfti-irow: 5; mso-yfti-lastrow: yes">
<td colspan="3" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 277.45pt; padding-right: 5.1pt; height: 26.15pt; border-top: #000000; border-right: black 2.25pt double; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-right-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" valign="top" width="370">
<p class="MsoNormal" style="line-height: 130%; margin: 0cm 0cm 0pt; background: white; vertical-align: baseline">
<font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 130%; font-family: 'hci poppy', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">(1) Bio-bank</span><span lang="EN-US" style="line-height: 130%; font-family: 'ÈÞ¸Õ¸íÁ¶', 'serif'; color: black; font-size: 11pt; mso-bidi-font-size: 12.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"> </span><span lang="EN-US" style="line-height: 130%; font-family: 'hci poppy', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">(2) Setting and Linking Big Data (3) High-tech Medical Clusters (4) Research-oriented Hospitals (5) Clinical Trials</span><span lang="EN-US" style="line-height: 130%; font-family: 'ÈÞ¸Õ¸íÁ¶', 'serif'; color: black; font-size: 11pt; mso-bidi-font-size: 12.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"> </span><span lang="EN-US" style="line-height: 130%; font-family: 'hci poppy', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">(6) Venture-Startup Platform</span><span lang="EN-US" style="line-height: 130%; font-family: '¹ÙÅÁ', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
<td colspan="2" style="border-bottom: black 1pt solid; border-left: #000000; padding-bottom: 1.4pt; background-color: transparent; padding-left: 5.1pt; width: 163.05pt; padding-right: 5.1pt; height: 26.15pt; border-top: #000000; border-right: black 1pt solid; padding-top: 1.4pt; mso-border-alt: solid black .25pt; mso-border-left-alt: double black 2.25pt; mso-border-top-alt: solid black .25pt" valign="top" width="217">
<p align="left" class="MsoNormal" style="text-align: left; line-height: 130%; margin: 5pt 0cm 0pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 130%; font-family: 'hci poppy', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="¸¼Àº °íµñ">(1) Specialized Generalists <span style="mso-spacerun: yes"> </span><o:p></o:p></font></span></p>
<p class="MsoNormal" style="line-height: 130%; margin: 0cm 0cm 0pt; background: white; vertical-align: baseline">
<font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 130%; font-family: 'hci poppy', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ÈÞ¸Õ¸íÁ¶; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">(2) Global Talents </span><span lang="EN-US" style="line-height: 130%; font-family: '¹ÙÅÁ', 'serif'; color: black; font-size: 11pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 10.0pt; mso-hansi-font-family: ±¼¸²; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p></o:p></span></font></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font face="Times New Roman"> </font></o:p></span></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; mso-para-margin-left: 0gd; mso-list: l4 level1 lfo2">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">1)<span style="font: 7pt 'times new roman'">      </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Based on excellent medical personnel, medical expertise, infrastructure and medical technologies, the government will develop areas where Korea can gain a comparative advantage. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l3 level1 lfo3">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Overseas Market Entry:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt"> With the aim of ensuring 162 medical institutions enter overseas markets by 2017, the government will strengthen its cooperation with foreign governments and promote the export of medical packages in which medical services, medicines, medical devices and medical technologies are bundled together to create synergy effects. (As of 2013, 111 medical institutions have made inroads into overseas markets). <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l3 level1 lfo3">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Medical Tourists:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt"> Korea aims to attract 500 thousand medical tourists into Korea in 2017 alone. To this end, the government will ensure the safety of medical tourism by preventing any market disrupting behaviors and diversify marketing channels, while beefing up PR activities by branding Korean medicine. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l3 level1 lfo3">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Blockbuster Drug: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Korea aims to develop as least one blockbuster drug by 2017. The government will encourage Koran pharmaceuticals strengthen their R&amp;D collaboration with global players and will create a policy fund to support domestic pharmaceuticals going overseas. (400 billion won in accumulation in 2015) <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l3 level1 lfo3">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Global Generics: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Korea will increase the number of global generic drugs that are approved in the US and Europe from 3 as of 2013 to 12 by 2017. The government will simplify the register and approval process in foreign markets through government-level cooperation, and support Korean pharmaceuticals in their efforts to fight patent infringement suits. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; mso-para-margin-left: 0gd; mso-list: l4 level1 lfo2">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">2)<span style="font: 7pt 'times new roman'">      </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Unlike already commercialized technologies, the government will accelerate the commercialization of new medical technology which holds a bright prospect of creating high added-value. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l1 level1 lfo4">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Genome and Customized Treatment:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt"> Korea will develop at least 4 types of diagnosis and treatment each. To this end, the government will focus its support on diagnosis that could be commercialized at earlier stages as well as on developing bio-markers. It will also render support for developing genetic variation chips which include Korean genome information and disease prediction models. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l1 level1 lfo4">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Stem Cell and Regenerative Medicine:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt"> Korea will gain at least 2 overseas approvals by 2017. The government will support companies develop innovative technologies for the next-generation of medicine, such as using 3D printing technology in producing stem cells. The government will encourage the participation of mid and large sized companies through international joint research and technology assessment. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l1 level1 lfo4">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">Antibiotics:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt"> Korea will lay the foundation for developing blockbuster level treatments by 2017. The government will support the development of relevant technology, offer financial support for clinical and non-clinical trials of candidates conducted at home and abroad and upgrade the manufacturing infrastructure of bio-medicine with the focus on state-of-the-art medical clusters. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; mso-para-margin-left: 0gd; mso-list: l1 level1 lfo4">
<font color="#000000"><font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">High-tech Medical Devices</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt">: Korea aims to advance source technology of high risk medical devices to clinical stages (two cases) by 2017. To this end, the government will identify promising technologies and support them throughout all stages from clinical stage to market entry.<span style="mso-spacerun: yes">  </span><o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 38pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l1 level1 lfo4">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><font color="#000000"><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt">Technology Licensing Office (TLO), a Dedicated Organization for Medical Technology</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt">: Korea will increase the number of technology transfer by TLO from the current 25 to 150 by 2017. To this end, the government will cultivate professionals by running medical technology management school, identify promising technology and do market analysis to support global licensing efforts. </span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 16pt; mso-fareast-font-family: ±¼¸²; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt"><o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l4 level1 lfo2">
<font face="Times New Roman"><font color="#000000"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt"><span style="mso-list: ignore">3)<span style="font: 7pt 'times new roman'">      </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt">The government will create new markets by developing new sales channels in overseas markets and by projecting the future after taking into account convergence between industries and the population aging, etc.<o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 28pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l0 level1 lfo5">
<font color="#000000"><font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt">Healthcare Product Export:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt"> Korea aims to export 2 pharmaceutical medical clusters. To this end, the government will offer support throughout the whole stages, including offering procurement information, funding overseas clinical trial expenses and offering help for local dispute settlement.</span></font><font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 115%; font-size: 12pt; mso-bidi-font-size: 11.0pt; mso-font-kerning: 0pt"> </span><span lang="EN-US" style="mso-font-kerning: 0pt"><o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 28pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l0 level1 lfo5">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Beauty Industry including Cosmetics:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"> Korea aims to increase the sales revenue of beauty and cosmetics products up to 31 trillion won by 2017 from 23 trillion won as of 2013. To this end, the government will support the efforts to develop global cosmetic brands, set up a support center for cosmetic product exports, conduct promotion activities such as holding a ‘K-beauty fair’ and improve regulatory framework to promote the beauty industry. <o:p></o:p></span></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 28pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l0 level1 lfo5">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Botanical Drugs:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"> Korea aims to transfer at least 2 related technologies overseas by 2017. To this end, the government will strengthen pharmaceutical product quality control and capabilities, and set up infrastructure for developing life resources. <o:p></o:p></span></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 28pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l0 level1 lfo5">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Healthy Aging Industry:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"> Korea aims to grow domestic market to 20 trillion won by 2017 from 14 trillion won as of 2013. In order to do so, the government will develop healthy aging service models and building healthy aging clusters that incorporate regional characteristics. <o:p></o:p></span></font></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l4 level1 lfo2">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">4)<span style="font: 7pt 'times new roman'">      </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">The government will strengthen the infrastructures of the healthcare industry and complete building platforms for all stages involving healthcare by increasing the connectivity between different medical infrastructures. <o:p></o:p></span></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l5 level1 lfo6">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Biobank: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Korea aims to increase the number of projects based on biobank data from around 1,000 in 2013 to over 2,000 by 2017. To this end, the government will collect clinical data standardized by disease and compile integrated Omics data. <b style="mso-bidi-font-weight: normal"><o:p></o:p></b></span></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 4.0gd">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="Times New Roman">*Omics data: <span style="mso-spacerun: yes"> </span>Data massively produced and compiled by analyzing genome, proteome and other human derived biomedical resources. <o:p></o:p></font></span></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l5 level1 lfo6">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Healthcare Big Data: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Korea aims to build an open data platform by 2017. The government will build a network of information systems and lay legal and regulatory frameworks to protect and manage private information. <b style="mso-bidi-font-weight: normal"><o:p></o:p></b></span></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt 40pt; background: white; vertical-align: baseline; word-break: keep-all">
<font face="Times New Roman"><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">* </span></b><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Building a network of information systems (e.g.): Connecting the information systems of National Health Insurance Service, Health Insurance Review and Assessment, National Center for Disease Prevention &amp; Control, and National Cancer Center.<o:p></o:p></span></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l5 level1 lfo6">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">High-tech Medical Clusters: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Korea will increase the number of R&amp;D centers located in medical clusters from 28 as of 2013 to 200 by 2017. The government will set up one-stop clinical trial support centers and attract renowned R&amp;D centers at home and abroad to these clusters so as to transform them into the world’s best.<span style="mso-spacerun: yes">  </span><b style="mso-bidi-font-weight: normal"><o:p></o:p></b></span></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l5 level1 lfo6">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Research-</span></b><font color="#000000"><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">oriented Hospitals: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">Korea aims to expand the share of R&amp;D spending as a share of revenue from 5 percent as of 2013 to 10 percent by 2017. To this end, the government will make preemptive investment in R&amp;D in a form of increased financial support to promote commercialization of R&amp;D and at the same time offer packaged support for key essential services such as collaborative study on major diseases and human resource training. <b style="mso-bidi-font-weight: normal"><span style="color: black; mso-font-kerning: 0pt"><o:p></o:p></span></b></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l5 level1 lfo6">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Clinical Trials:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²"><font color="#000000"> Korea aims to become the global top 7 by 2017 in terms of clinical trial competitiveness (as of 2013, Korea ranks the global top 10). The government will cultivate professionals, support the development of new technology for clinical trials and augment relevant infrastructures including the set-up of a ‘global clinical trial innovation center.’ <span style="mso-spacerun: yes">  </span><b style="mso-bidi-font-weight: normal"><span style="color: black; mso-font-kerning: 0pt"><o:p></o:p></span></b></font></span></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l5 level1 lfo6">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt">Healthcare Venture-</span></b><font color="#000000"><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">Startups: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">Korea aims to support 40 venture-startups by 2017. <b style="mso-bidi-font-weight: normal"><span style="mso-spacerun: yes"> </span></b>To this end, the government will leverage the infrastructure of high-tech medical clusters to build healthcare venture-startup platforms and render financial support for companies developing early-stage technologies. <b style="mso-bidi-font-weight: normal"><span style="color: black; mso-font-kerning: 0pt"><o:p></o:p></span></b></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l4 level1 lfo2">
<font color="#000000"><font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: 'times new roman'"><span style="mso-list: ignore">5)<span style="font: 7pt 'times new roman'">      </span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">The government will nurture capable individuals who will lead the future healthcare industry. <o:p></o:p></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l6 level1 lfo7">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><font color="#000000"><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">Specialized Generalists: </span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">As of 2013, it is anticipated that around 20 thousand specialized generalists will be required additionally by 2017. Thus, the government will formulate plans to systemically develop high-potential individuals with knowledge in convergence and strengthen cooperation with relevant agencies and institutions. <b style="mso-bidi-font-weight: normal"><span style="color: black; mso-font-kerning: 0pt"><o:p></o:p></span></b></span></font></font></p>
<p class="MsoListParagraph" style="text-indent: -20pt; margin: 0cm 0cm 10pt 40pt; background: white; vertical-align: baseline; word-break: keep-all; mso-para-margin-left: 0gd; mso-list: l6 level1 lfo7">
<font face="Times New Roman"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: 'times new roman'; mso-font-kerning: 0pt"><span style="mso-list: ignore">-<span style="font: 7pt 'times new roman'">           </span></span></span><font color="#000000"><b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²">Global Talents:</span></b><span lang="EN-US" style="line-height: 115%; font-family: 'times new roman', 'serif'; font-size: 12pt; mso-fareast-font-family: ±¼¸²"> Korea aims to increase the number of medical personnel stationed overseas from 75 in 2013 to 500 in 2017 alone. The government will run educational programs for medical staff working overseas including nurses and medical interpreters. In addition, the government will expand global expert training programs and promote the global collaborative network for healthcare to nurture global talents. <b style="mso-bidi-font-weight: normal"><span style="color: black; mso-font-kerning: 0pt"><o:p></o:p></span></b></span></font></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt 20pt; background: white; vertical-align: baseline; word-break: keep-all">
<b style="mso-bidi-font-weight: normal"><span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font face="Times New Roman"> </font></o:p></span></b></p>
<p class="MsoNormal" style="margin: 0cm 0cm 8pt 20pt; background: white; vertical-align: baseline; word-break: keep-all">
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="Times New Roman">This plan is a basic design of how the healthcare industry will develop and what the policy priorities are. Concrete timeline and budget allocation for each area will be determined in line with relevant inter-agency level plans such as ‘Future Strategy for Bid-med.’<span style="mso-spacerun: yes">   </span><o:p></o:p></font></span></p>
<p>
<span lang="EN-US" style="line-height: 107%; font-family: 'times new roman', 'serif'; color: black; font-size: 12pt; mso-fareast-font-family: ±¼¸²; mso-font-kerning: 0pt; mso-ansi-language: en-us; mso-fareast-language: ko; mso-bidi-language: ar-sa"><font face="Times New Roman">An official of the Ministry of Health and Welfare emphasized the significance of the plan by saying, “The ‘Healthcare Industry Promotion Plan’ is a testament to the firm determination of the Ministry as it voluntarily set up the goals and painted a big picture under which it plans to work systemically.”</font></span></p></td>
</tr>
<tr>
<th scope="row">File</th>
<td colspan="3">
<p><img alt="" src="../../images/common/file/icon_file.gif"/> <a href="../../../download.mohw.go.kr/front_new/modules/cd4862a684b3382a7f13447b1f607471">[ENG]_[4.7]Health_Industry_Blueprint[3].docx (43 KB / Download : 264)</a></p>
</td>
</tr>
</tbody>
</table>
<!-- /table:view -->
<!-- ÇÏ´Ü ¹öÆ° ¿µ¿ª -->
<div class="btn btm">
<!--  ¿À¸¥ ÂÊ ¿µ¿ª ¹öÆ° -->
<a href="3fbff7a5c45a170ce3270ba839fff4fb"><img alt="list" class="right" src="../../images/eng/common/btn_list.gif"/></a>
<!--  /¿À¸¥ ÂÊ ¿µ¿ª ¹öÆ° -->
</div>
<!-- /ÇÏ´Ü ¹öÆ° ¿µ¿ª -->
</form>
<br/>
<br/>
<div class="view_list">
<form action="ssg0111ls.jsp" method="post" name="fmList">
<input name="PAR_MENU_ID" type="hidden" value="1001"/>
<input name="MENU_ID" type="hidden" value="100111"/>
<input name="page" type="hidden" value="19"/>
<input name="SEARCHKEY" type="hidden" value=""/>
<input name="SEARCHVALUE" type="hidden" value=""/>
<input name="CONT_SEQ" type="hidden" value=""/>
<!-- table head above list -->
<div id="tablehead">
<p>Total <strong>345</strong> Articles</p>
</div>
<!-- /table head above list -->
<table class="list" summary="Publication list.">
<caption>Publication</caption>
<colgroup>
<col width="8%"/><col width="60%"/>
<col width="16%"/><col width="8%"/><col width="8%"/>
</colgroup>
<thead>
<tr>
<th class="first" scope="col">No</th>
<th scope="col">Subject</th>
<th scope="col">Date</th>
<th scope="col">File</th>
<th scope="col">Hit</th>
</tr>
</thead>
<tbody>
<tr>
<td>165</td>
<td class="left"><a href="f52529847bc5dffb435a4a975b5d8751">2014 Status Report on Sharing</a></td>
<td>2015-05-12</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1877</td>
</tr>
<tr>
<td>164</td>
<td class="left"><a href="4f38eef8c28c8daca3fe90145ff0ea52"><strong>Government Unveils a Blueprint for the Healthcare ...</strong></a></td>
<td>2015-04-23</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2374</td>
</tr>
<tr>
<td>163</td>
<td class="left"><a href="ed93661555ab8629b085132795a1a723">Creating Results through Enhanced Medical Cooperat...</a></td>
<td>2015-03-24</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2462</td>
</tr>
<tr>
<td>162</td>
<td class="left"><a href="fb88d92356abe6bea9aabe8d30f4bbc9">Government to Enhance Foreign Patient Protection</a></td>
<td>2015-02-23</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>3271</td>
</tr>
<tr>
<td>161</td>
<td class="left"><a href="ef23fe486c11d07ec97ac636ad27f6b1">[ENG][1.27]_Eradicating_Child_Abuse</a></td>
<td>2015-02-04</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2735</td>
</tr>
<tr>
<td>160</td>
<td class="left"><a href="3ff64d9e2a6b9a3fe3a2976e5d2f50d6">[ENG] E-Cigarette_is_Cigarette,_Not_Smoking_Cessat...</a></td>
<td>2015-01-12</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2828</td>
</tr>
<tr>
<td>159</td>
<td class="left"><a href="b51b23fd5abdf3ba9edea89e1f7b893e">NationalPension Develops 5 Year Investment Plan</a></td>
<td>2014-12-24</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2861</td>
</tr>
<tr>
<td>158</td>
<td class="left"><a href="e867d7ee9cfb2a13cb264009d547fa7c">AIDS is Nothing to be Afraid of, if You are Rightl...</a></td>
<td>2014-12-04</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2930</td>
</tr>
<tr>
<td>157</td>
<td class="left"><a href="1293f6bdb855b11b552f72cd50dc6d45">Hospitals Designated for Ebola Treatment Will Form...</a></td>
<td>2014-12-01</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2523</td>
</tr>
<tr>
<td>156</td>
<td class="left"><a href="59bb0d7d56ec0197d6940611e6b09569">Ecuadorian Delegation Visits Korea to Review Korea...</a></td>
<td>2014-11-10</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>3494</td>
</tr>
</tbody>
</table>
<!-- /table:list -->
<!-- paging -->
<!-- paging -->
<div id="paging">
<a class="btn" href="ebfb6bc3f850eb20122e1021c6e4c0d1"><img alt="first page" src="../../images/eng/common/btn_firstpage.gif"/></a>
<a class="btn" href="ffdc4366d327476f2a2bdd61bea75d3f"><img alt="pre page" src="../../images/eng/common/btn_prepage.gif"/></a>
<a href="b5ac7ead72941feddd2152cd97408423" title="11page">11</a> 

				<a href="43305223367df6986d635c77763975b3" title="12page">12</a> 

				<a href="2711dbddb6de0a13625580768c3557fa" title="13page">13</a> 

				<a href="291c7b2c06ad0f481977e50fbd85795e" title="14page">14</a> 

				<a href="69279edea38f89c531ee92dcc558f429" title="15page">15</a> 

				<a href="3d5e6982b8cfbd3ae4834a4e77e21144" title="16page">16</a> 

				<a href="32fde42f13158f6b4f430ac227830ad3" title="17page">17</a> 

				<a href="e9a17658ff68b1011b3bf38b014eea17" title="18page">18</a> 

				<span title="present">19</span> 

				<a href="095823f82b64fc9c0ab92d552e48e0b3" title="20page">20</a> 

				<a class="btn" href="6c8765ade6af448afd7277d09046c33a"><img alt="next page" src="../../images/eng/common/btn_nextpage.gif"/></a>
<a class="btn" href="2d7e34ab1d5e2a71b1530de73fd24299"><img alt="last page" src="../../images/eng/common/btn_lastpage.gif"/></a>
</div>
<!-- /paging -->
<!-- /paging -->
</form>
<!-- DB ¿¡¼­ contents µ¥ÀÌÅÍ¸¦ °¡Á®¿Í¼­ »Ñ·ÁÁØ´Ù. -->
</div>
</div>
<!-- /contents -->
</div>
</div>
<!-- footer -->
<!-- footer -->
<div id="footer">
<div class="foot">
<p class="flogo"><img alt="ministry of health and welfare" src="../../images/eng/common/flogo.gif"/></p>
<div class="finfo">
<address><img alt="13, Doum 4-ro, Sejong, (30113) Korea ¤ÓCALL CENTER 82-129" src="../../images/eng/common/foot_address.gif"/></address>
<p class="copyright"><img alt="Copyright(C) By MOHW. All rights reserved." src="../../images/eng/common/foot_copyright.gif"/></p>
</div>
<!-- ÀÏÀÏ¹æ¹®ÀÚ¼ö Ãß°¡ -->
<p class="visits">Daily visits : <strong>198</strong></p>
<!--// ÀÏÀÏ¹æ¹®ÀÚ¼ö Ãß°¡ -->
</div>
</div>
<!-- //footer -->
</div>
<div id="returntotop"><a href="#skip-navi">go to the top</a></div>
<script type="text/javascript">
//<![CDATA[
function jsOpenSite(formEl) {	
	var errorMessage = null;
	var objFocus = null;
	if (formEl.sitelink.value.length == 0) {
		errorMessage = "please! select a site to move!";
		objFocus = formEl.sitelink;
	} 
	if(errorMessage != null) {
		alert(errorMessage);
		objFocus.focus();
		return false;
	}
	return true;
}
//]]>	
</script>
<script type="text/javascript">
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-101800795-1', 'auto');
  ga('send', 'pageview');

</script>
<!-- /footer -->
</div>
</body>
</html>